{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:34:57Z","timestamp":1740155697810,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/nrcardio.2014.89","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T08:43:23Z","timestamp":1403599403000},"page":"440-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment for low-risk patients with STEMI\u2014challenges remain"],"prefix":"10.1038","volume":"11","author":[{"given":"Tariq","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"key":"BFnrcardio201489_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs289","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg, P. G.  et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 33, 2569\u20132619 (2012).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201489_CR2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt, B.  et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309\u20131321 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"BFnrcardio201489_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"Bertram Pitt","year":"1999","unstructured":"Pitt, B.  et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709\u2013717 (1999).","journal-title":"New England Journal of Medicine"},{"key":"BFnrcardio201489_CR4","doi-asserted-by":"publisher","unstructured":"Montalescot, G.  et al. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized double-blind REMINDER study. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehu164\n                    \n                  .","DOI":"10.1093\/eurheartj\/ehu164"},{"key":"BFnrcardio201489_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","volume":"333","author":"KA Fox","year":"2006","unstructured":"Fox, K. A.  et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333, 1091 (2006).","journal-title":"BMJ"},{"key":"BFnrcardio201489_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad, F.  et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364, 11\u201321 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201489_CR7","unstructured":"Yancy, C. W.  et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College Of Cardiology Foundation\/American Heart Association Task Force On Practice Guidelines. J. Am. Coll. Cardiol. 15, e147\u2013e239 (2013)."},{"key":"BFnrcardio201489_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/CIRCULATIONAHA.112.120485","volume":"127","author":"JL Januzzi","year":"2013","unstructured":"Januzzi, J. L. & Troughton, R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation 127, 500\u2013507 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio201489_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jacc.2013.06.009","volume":"62","author":"GM Felker","year":"2013","unstructured":"Felker, G. M. & Ahmad, T. Natriuretic peptides and primary prevention: the new world? J. Am. Coll. Cardiol. 62, 1373\u20131375 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"BFnrcardio201489_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ahj.2013.06.020","volume":"166","author":"Krishnasree K. Rao","year":"2013","unstructured":"Rao, K. K.  et al. Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With The Guidelines (GWTG). Am. Heart J. 166, 709\u2013715 (2013).","journal-title":"American Heart Journal"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.89","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:55:27Z","timestamp":1684468527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,24]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFnrcardio201489"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2014.89","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"type":"print","value":"1759-5002"},{"type":"electronic","value":"1759-5010"}],"subject":[],"published":{"date-parts":[[2014,6,24]]},"assertion":[{"value":"24 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}